Drugs of Abuse Test iCassette Dx 11-Drug Panel AMP, BAR, BZO, COC, MDMA, OPI 300, OXY, PCP, PPX, TCA, THC Urine Sample 25 Tests CLIA Waived

By Mckesson
0
(0)
0 218
$409.04
Out of Stock

728540

Description

iCassette Dx Drug Screen Detects 11 drugs simultaneously. Recommended Control is 811462 (iScreen Urine Drug Control Kit - Mfg #88004). A total of 3 drops should enter each well and 5 minutes should expire before results are recorded. Integrated Positive and Negative procedural controls. iCassette DX External Controls - iScreen Urine Drug Control Kit Alere # 88004. Result Form 2380P or Mckesson # 536563. iCassette uses a pipette device to engage the urine sample and drops it into wells located on the bottom of the iCassette drug screen test


Specification

  • Application : Drugs of Abuse Test
  • CLIA Classification : CLIA Waived
  • Contents 1 : (25) Test Devices, Disposable Droppers, Package Insert
  • Number of Tests : 25 Tests
  • Product Dating : McKesson Acceptable Dating: we will ship >= 90 days
  • Reading Type : Visual Read
  • Sample Type : Urine Sample
  • Test Format : Cassette Format
  • Test Name : AMP, BAR, BZO, COC, MDMA, OPI 300, OXY, PCP, PPX, TCA, THC
  • Test Type : 11-Drug Panel
  • Time to Results : 5 Minute Results
  • UNSPSC Code : 41116146

Attachment : Product Specification Sheet

Vendor McKesson
Price Range $101 - $200
Shipping Cost
Shop Location Irving, Texas (TX), United States (US)

No reviews found!

No comments found for this product. Be the first to comment!

Welcome to shop.mhsurgicals.com..! In order to provide a more relevant experience for you, we use cookies to enable some website functionality. Cookies help us see which articles most interest you. This website or its third-party tools process personal data (e.g. browsing data or IP addresses) and use cookies or other identifiers, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy.

You accept the use of cookies by closing or dismissing this notice, To learn more, please refer to the Cookie policy.